» Authors » S Radulovic

S Radulovic

Explore the profile of S Radulovic including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 120
Citations 861
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Malisic E, Jankovic R, Majkic M, Dobricic J, Radulovic S
J BUON . 2009 Jan; 13(4):525-32. PMID: 19145674
Purpose: The incidence rate (age-standardized) of cervical carcinoma in Serbia is the highest in Europe. p53 is mainly inactivated at protein level in carcinomas associated with human papillomavirus (HPV) infection,...
12.
Konjevic G, Jovic V, Vuletic A, Radulovic S, Jelic S, SPUZIC I
Eur J Clin Invest . 2007 Nov; 37(11):887-96. PMID: 17973783
Background: The few chemoimmunotherapy trials that together with dacarbazine (DTIC) and interferon-alpha 2a (IFNalpha), include retinoic acid (RA), did not include detailed immunological evaluation of functional and phenotypic natural killer...
13.
Susnjar S, Bosnjak S, Radulovic S, Stevanovic J, Gajic-Dobrosavljevic M, Kreacic M
J BUON . 2007 Jun; 12(2):189-96. PMID: 17600871
Purpose: Capecitabine and paclitaxel show high efficacy, non-overlapping toxicity profiles and preclinical synergism, providing the rationale for their combination in metastatic breast cancer (MBC). This dose-escalation study aimed at determining...
14.
Brankovic-Magic M, Radulovic S
J BUON . 2007 Jun; 7(2):97-8. PMID: 17577269
No abstract available.
15.
Bjelogrlic S, Srdic T, Radulovic S
J BUON . 2007 Apr; 12(1):71-6. PMID: 17436405
Purpose: The reduced folate leucovorin (LV) has been used for over 30 years as an enhancer of 5-fluorouracil (5-FU) antitumor activity. CoFactor (CoF) is a calcium salt of LV's active...
16.
Jankovic R, Brankovic-Magic M, Radulovic S
J BUON . 2007 Apr; 9(4):347-54. PMID: 17415838
Carcinogenesis represents a multistep process associated with accumulation of somatic mutations in the classes of genes that regulate cell proliferation, apoptosis as well as DNA repair. Oncogenes, positive regulators of...
17.
Mitrovic T, Radulovic S
J BUON . 2007 Mar; 10(2):167-73. PMID: 17343324
The original concept of gene therapy was the introduction of a healthy copy of gene into an ill human cell in order to correct gene defects in monogenic hereditary diseases....
18.
Jezdic S, Bountouroglou N, Iordanov V, Athanassiou A, Radulovic S, Kinay M, et al.
J BUON . 2007 Feb; 11(3):277-80. PMID: 17309149
No abstract available.
19.
Bjelogrlic S, Srdic T, Radulovic S
J BUON . 2007 Feb; 11(3):267-76. PMID: 17309148
Mammalian target of rapamycin (mTOR) is a serine-threonine kinase member of the cellular phosphatidylinositol 3-kinase (P13K) pathway. The P13K/Akt signaling pathway plays a critical role in regulating basic cellular functions...
20.
Arandjelovic S, Tesic Z, Perego P, Gatti L, Carenini N, Zunino F, et al.
Med Chem . 2006 Sep; 2(3):227-37. PMID: 16948468
The aim of this study was to investigate cellular response to several ruthenium(III), chromium(III) and rhodium(III) compounds carrying bidentate beta-diketonato ligands: [(acac)--acetylacetonate ligand, (tfac)--trifluoroacetylacetonate ligand]. Cell sensitivity studies were performed...